1. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition
   Yan Zhou et al, 2016, Front. Pharmacol. CrossRef
2. The efficacy of plant extract and bioactive compounds approaches in the treatment of pulmonary fibrosis: A systematic review
   Sana Bahri et al, 2017, Biomedicine & Pharmacotherapy CrossRef
3. Modeling alveolar injury using microfluidic co-cultures for monitoring bleomycin-induced epithelial/fibroblastic cross-talk disorder
   Jiarui He et al, 2017, RSC Adv. CrossRef
4. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis
   Qi Liu et al, 2017, Toxicology Letters CrossRef
5. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects.
   Liu-Cheng Li et al, 2017, J Ethnopharmacol CrossRef
6. Effectiveness and safety of Chinese medicine for Idiopathic pulmonary fibrosis: A systematic review and meta-analysis
   Qi Wu et al, 2018, Chin. J. Integr. Med. CrossRef
7. Preparation and Quality Evaluation of Salvianolic Acids and Tanshinones Dry Powder Inhalation
   Jianhong Wang et al, 2018, Journal of Pharmaceutical Sciences CrossRef
8. Tanshinone IIA activates nuclear factor-erythroid 2-related factor 2 to restrain pulmonary fibrosis via regulation of redox homeostasis and glutaminolysis
   Lin An et al, 2018, Antioxidants & Redox Signaling CrossRef
9. Effects of plant extracts and bioactive compounds on attenuation of bleomycin-induced pulmonary fibrosis
   Sarasadat Hosseini et al, 2018, Biomedicine & Pharmacotherapy CrossRef
10. Effect of Phoenix dactylifera L. Sap Against Bleomycin-Induced Pulmonary Fibrosis and Oxidative Stress in Rats: Phytochemical and Therapeutic Assessment
    Sana Bahri et al, 2019, Nutrition and Cancer CrossRef
11. Danshen: a phytochemical and pharmacological overview.
    Xiao-Dan MEIm et al, 2019, Chin J Nat Med CrossRef
12. Integrated Therapy Decreases the Mortality of Patients with Polymyositis and Dermatomyositis: A Taiwan-wide Population-Based Retrospective Study
    Ching-Mao Chang et al, 2019, Journal of Ethnopharmacology CrossRef
13. Ability to Suppress TGF-β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions
    Rui Shao et al, 2019, Front. Pharmacol. CrossRef
14. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the novel peptide EZY-1 purified from Eucheuma
    Huajun Yu et al, 2019, Food Funct. CrossRef
15. Salvia miltiorrhiza Restrains Reactive Oxygen Species-Associated Pulmonary Fibrosis via Targeting Nrf2-Nox4 Redox Balance
    Li-Ying Peng et al, 2019, Am. J. Chin. Med. CrossRef
16. Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China
    Luca Richeldi et al, 2015, BMC Med CrossRef
17. Tanshinone IIA treatment alleviated the rat gingival connective tissue overgrowth induced by cyclosporine A
    S. Ma et al, 2016, J Periodont Res CrossRef
18. Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4-NF-κB Pathway.
    Guanwei Fan et al, 2016, Inflammation CrossRef
19. Propolis protects against bleomycin-induced pulmonary fibrosis through mitochondrial-dependent pathway
    Dalia I. Ismail et al, 2015, The Egyptian Journal of Histology CrossRef
20. Conventional Western Treatment Combined With Chinese Herbal Medicine Alleviates the Progressive Risk of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
    Tsai-Hui Lin et al, 2019, Front. Pharmacol. CrossRef
21. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway
    Feifei Feng et al, 2020, Biomedicine & Pharmacotherapy CrossRef
22. Alpha-Mangostin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice Partly Through Activating Adenosine 5′-Monophosphate-Activated Protein Kinase
    Ren-shi Li et al, 2019, Front. Pharmacol. CrossRef
23. Cryptotanshinone reverses the epithelial-mesenchymal transformation process and attenuates bleomycin-induced pulmonary fibrosis
    Qianyu Zhang et al, 2020, Phytotherapy Research CrossRef
24. NOGO-B promotes EMT in lung fibrosis via MMP14 mediates free TGF-beta1 formation
    Ye Xiong et al, 2017, Oncotarget CrossRef
25. Salvianolic acid B and sodium tanshinone II A sulfonate prevent pulmonary fibrosis through anti-inflammatory and anti-fibrotic process
    Linxia Jiang et al, 2020, European Journal of Pharmacology CrossRef
26. Yiqi Yangyin Huoxue Method in Treating IdiopathicPulmonary Fibrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Min Zhou et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
27. Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential
    Yukun Zhang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
28. The role of natural products in the prevention and treatment of pulmonary fibrosis: a review
    Liqun Wang et al, 2021, Food Funct. CrossRef
29. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial
    Zhen-Hui Lu et al, 2021, Infect Dis Poverty CrossRef
30. Combination therapy of tanshinone IIA and puerarin for pulmonary fibrosis via targeting IL6-JAK2-STAT3/STAT1 signaling pathways.
    Zhifeng Xue et al, 2021, Phytother Res CrossRef
31. Sodium Tanshinone IIA Sulfonate Attenuates Cigarette Smoke Extract-Induced Mitochondrial Dysfunction, Oxidative Stress, and Apoptosis in Alveolar Epithelial Cells by Enhancing SIRT1 Pathway
    Ruijuan Guan et al, 2021 CrossRef
32. Evaluating the Therapeutic Mechanisms of Selected Active Compounds in Houttuynia cordata Thunb. in Pulmonary Fibrosis via Network Pharmacology Analysis
    De-Wei Zhu et al, 2021, Front. Pharmacol. CrossRef
33. Protective effect of dapsone against bleomycin-induced lung fibrosis in rat
    Hasan Yousefi-Manesh et al, 2021, Experimental and Molecular Pathology CrossRef
34. Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
    Cristina Estornut et al, 2022, Front. Pharmacol. CrossRef
35. Screening and evaluation of quality markers from Shuangshen Pingfei granules for idiopathic pulmonary fibrosis using network pharmacology and pharmacodynamic, phytochemical, and pharmacokinetic analyses
    Chen Yeqing et al, 2022, Phytomedicine CrossRef
36. Herbal bioactives for pulmonary drug delivery systems
    Reshu Virmani et al, 2022 CrossRef
37. An Overview of Herbal Medicines for Idiopathic Pulmonary Fibrosis
    Pavitra Murthy et al, 2022, Processes CrossRef
38. Intervention Mechanism of Niao Du Kang Mixture on the EMT Process of Peritoneal Fibrosis Based on the Wnt/β-Catenin Signaling Pathway
    Lin Huang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
39. Theophylline attenuates bleomycin-induced oxidative stress in rats: The role of IL-6, NF-κB, and antioxidant enzymes
    Suat Ekin et al, 2022, Braz. J. Pharm. Sci. CrossRef
40. Alveolar organoids: development of an in vitro assay to facilitate pulmonary toxicity assessments
    Jooyeon Lee et al, 2022, Organoid CrossRef
41. Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms
    Yanwei Hao et al, 2023, Journal of Ethnopharmacology CrossRef
42. Screening study on significant Chinese herb for anti-idiopathic pulmonary fibrosis by combining clinical experience prescriptions and molecular dynamics simulation technologies
    Haiting Yan et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
43. Traditional Herbal Medicines, Bioactive Compounds, and Plant Products as Therapeutic Approach Against Interstitial Lung Disease
    Lovely Sinha et al, 2023 CrossRef
44. Regulation of miRNA-155-5p ameliorates NETosis in pulmonary fibrosis rat model via inhibiting its target cytokines IL-1β, TNF-α and TGF-β1
    Rana Mostafa Adel et al, 2024, International Immunopharmacology CrossRef
45. Tanshinone IIA alleviates bleomycin-induced pulmonary fibrosis by inhibiting Zbtb16
    Huijuan Zhang et al, 2024, Pulmonary Pharmacology & Therapeutics CrossRef
46. Tanshinone IIA ameliorates energy metabolism dysfunction of pulmonary fibrosis using 13C metabolic flux analysis
    Baixi Shan et al, 2023, Journal of Pharmaceutical Analysis CrossRef
47. Time-/dose-series transcriptome data analysis and traditional Chinese medicine treatment of pneumoconiosis
    Jifeng Zhang et al, 2024, International Journal of Biological Macromolecules CrossRef
48. Monomeric compounds from natural products for the treatment of pulmonary fibrosis: a review
    Zhuqing Li et al, 2024, Inflammopharmacol CrossRef
49. Effects of Tanshinone IIA on Cognitive Impairment in Alzheimer’s Disease Rats Via Oxidative Stress, Inflammatory Responses and Apoptosis
    Wujiang Ren et al, 2024, Pharmacognosy Magazine CrossRef
50. Research progress on the use of Salvia miltiorrhiza Bunge extracts in the treatment of pulmonary diseases
    Peifeng Huang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
51. Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
    Megh Pravin Vithalkar et al, 2025, International Immunopharmacology CrossRef